Cl
Clovis Oncology
Boulder COFounded 2009200 employees
Private CapbiotechAcquiredOncology
Platform: Rubraca PARP
Market Cap
N/A
All Drugs
3
Clinical Trials
3
Failed / Terminated
0
FDA Approved
0
Drug Pipeline (3 programs)
| Drug Name | Code | Phase | Trials | Modality | Target | MOA | Indications |
|---|---|---|---|---|---|---|---|
| CLO-5164 | CLO-5164 | Phase 1 | 1 | Nectin-4 | LGS | ||
| CLO-2738 | CLO-2738 | NDA/BLA | 1 | TROP-2 | Ovarian Ca | ||
| CLO-7126 | CLO-7126 | Preclinical | 1 | PARP | WilmsNB |
Financial Documents
This company has been acquired — see parent company for financial filings.
Catalyst Events (4)